0001209191-19-005355.txt : 20190125 0001209191-19-005355.hdr.sgml : 20190125 20190125164010 ACCESSION NUMBER: 0001209191-19-005355 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190123 FILED AS OF DATE: 20190125 DATE AS OF CHANGE: 20190125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martell Robert CENTRAL INDEX KEY: 0001529922 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30347 FILM NUMBER: 19542979 MAIL ADDRESS: STREET 1: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURIS INC CENTRAL INDEX KEY: 0001108205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043505116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-503-6500 MAIL ADDRESS: STREET 1: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-23 0 0001108205 CURIS INC CRIS 0001529922 Martell Robert 4 MAGUIRE ROAD LEXINGTON MA 02421 0 1 0 0 Head of Research & Development Common Stock 2019-01-23 4 F 0 8473 1.07 D 28527 D Common Stock 2019-01-23 4 S 0 5500 1.0728 D 23027 D Shares were withheld by the Company to satisfy minimum statutory withholding requirements related to a vesting of a service-based restricted stock award granted on January 22, 2018. On May 29, 2018, the Company effected a 1-for-5 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. This transaction was effected pursuant to a Rule 10b5-1 trading plan to cover tax obligations. The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.09, inclusive. The reporting person undertakes to provide to Curis, Inc., any security holder of Curis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth on this Form 4. William Steinkrauss, attorney-in-fact 2019-01-25